Advertisement

Hyperinsulinemia is an independent predictor for complex atherosclerotic lesion of thoracic aorta in non-diabetic patients

      Abstract

      Objective

      Hyperinsulinemia is a well known risk factor for cardiovascular event. However, it is not known whether hyperinsulinemia facilitates atherosclerotic complex lesions of aorta in non-diabetic patients. We investigated whether hyperinsulinemia is an independent marker of severity of atherosclerosis in thoracic aorta of non-diabetic patients using multiplane transesophageal echocardiography (TEE).

      Research design and methods

      Non-diabetic 90 patients with cardiovascular disease underwent TEE, and were analyzed for plasma insulin levels of oral glucose tolerance test, conventional atherosclerotic risk factors and coronary angiographic features.

      Results

      Thoracic aortic plaques were detected in 84 patients (93%). The complex atherosclerotic lesions were observed in 35 (39%) patients, most frequently at the part of aortic arch (p < 0.005), showing the greatest atheroma score in thoracic aorta (p < 0.05). Univariate analysis showed age, male gender, smoking, coronary artery disease, HDL-cholesterol, insulin levels in glucose tolerance test and homeostasis model assessment insulin resistance index (HOMA index) were found to be significant predictors of complex atherosclerotic lesions. Multivariate regression analysis revealed that HOMA index was an independent predictor of complex atherosclerotic lesions (odds ratio 1.93, p = 0.006). There was a significant positive correlation between HOMA index and the atheroma score of thoracic aorta (p < 0.001).

      Conclusions

      Hyperinsulinemia is an independent predictor of complex atherosclerotic lesions detected by TEE in the thoracic aorta of non-diabetic patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reaven G.M.
        Banting lecture 1988: role of insulin resistance in human disease.
        Diabetes. 1988; 37: 1595-1607
        • Kaplan N.M.
        The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.
        Arch Intern Med. 1989; 149: 1514-1520
        • DeFronzo R.A.
        • Ferrannini E.
        Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
        Diabetes Care. 1991; 14: 173-194
        • Despres J.P.
        • Lamarche B.
        • Mauriege P.
        • et al.
        Hyperinsulinemia as an independent risk factor for ischemic heart disease.
        N Engl J Med. 1996; 334: 952-957
        • Pyorala M.
        • Miettinen H.
        • Laakso M.
        • et al.
        Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study.
        Circulation. 1998; 98: 398-404
        • Agmon Y.
        • Khandheria B.K.
        • Meissner I.
        • et al.
        Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population.
        Am J Cardiol. 2002; 89: 262-267
        • The French Study of Aortic Plaques in Stroke Group
        Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke.
        N Engl J Med. 1996; 334: 1216-1221
        • Montgomery D.H.
        • Ververis J.J.
        • McGorisk G.
        • et al.
        Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study.
        J Am Coll Cardiol. 1996; 27: 95-101
        • Reynolds H.R.
        • Tunick P.A.
        • Kort S.
        • et al.
        Abdominal aortic aneurysms and thoracic aortic atheromas.
        J Am Soc Echocardiogr. 2001; 14: 1127-1131
        • Matsuzaki M.
        • Ono S.
        • Tomochika Y.
        • et al.
        Advances in transesophageal echocardiography for the evaluation of atherosclerotic lesions in thoracic aorta—the effects of hypertension, hypercholesterolemia, and aging on atherosclerotic lesions.
        Jpn Circ J. 1992; 56: 592-602
        • Ribakove G.H.
        • Katz E.S.
        • Galloway A.C.
        • et al.
        Surgical implications of transesophageal echocardiography to grade the atheromatous aortic arch.
        Ann Thorac Surg. 1992; 53: 758-761
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
      1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

        • Howard G.
        • O’Leary D.H.
        • Zaccaro D.
        • et al.
        Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
        Circulation. 1996; 93: 1809-1817
        • Imazu M.
        • Sumii K.
        • Yamamoto H.
        • et al.
        Hyperinsulinemia as a risk factor for restenosis after coronary balloon angioplasty.
        Jpn Circ J. 2001; 65: 947-952
        • Tsuchihashi K.
        • Hikita N.
        • Hase M.
        • et al.
        Role of hyperinsulinemia in atherosclerotic coronary arterial disease: studies of semi-quantitative coronary angiography.
        Intern Med. 1999; 38: 691-697
        • Fujino T.
        • Ishii Y.
        • Takeuchi T.
        • et al.
        Recovery of BMIPP uptake and regional wall motion in insulin resistant patients following angioplasty for acute myocardial infarction.
        Circ J. 2003; 67: 757-762
        • Marinho N.V.
        • Keogh B.E.
        • Costa D.C.
        • et al.
        Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.
        Circulation. 1996; 93: 737-744
        • Baron A.D.
        Hemodynamic actions of insulin.
        Am J Physiol. 1994; 267: E187-E202
        • Kashiwagi A.
        • Shinozaki K.
        • Nishio Y.
        • et al.
        Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats.
        Am J Physiol. 1999; 277: E976-E983
        • Ridray S.
        • Heudes D.
        • Michel O.
        • Penicaud L.
        • Ktorza A.
        Increased SMC proliferation after endothelial injury in hyperinsulinemic obese Zucker rats.
        Am J Physiol. 1994; 267: H1976-H1983
        • Kawabe J.
        • Aizawa Y.
        • Takehara N.
        • Hasebe N.
        • Kikuchi K.
        Glucose modifies the cross-talk between insulin and the beta-adrenergic signaling system in vascular smooth muscle cells.
        J Hypertens. 2000; 18: 1457-1464
        • Solberg L.A.
        • Strong J.P.
        Risk factors and atherosclerotic lesions: a review of autopsy studies.
        Arteriosclerosis. 1983; 3: 187-198
        • Kallikazaros I.E.
        • Tsioufis C.P.
        • Stefanadis C.I.
        • Pitsavos C.E.
        • Toutouzas
        Close relation between carotid and ascending aortic atherosclerosis in cardiac patients.
        Circulation. 2000; 102: 263-268
        • Uekita K.
        • Hasebe N.
        • Funayama N.
        • et al.
        Cervical and intracranial atherosclerosis and silent brain infarction in Japanese patients with coronary artery disease.
        Cerebrovasc Dis. 2003; 16: 61-68
        • Peltier M.
        • Iannetta Peltier M.C.
        • Sarano M.E.
        • et al.
        Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis.
        Chest. 2002; 121: 1589-1594
        • Aizawa Y.
        • Kawabe J.
        • Hasebe N.
        • Takehara N.
        • Kikuchi K.
        Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia.
        Circulation. 2001; 104: 455-460
        • Koshiyama H.
        • Shimono D.
        • Kuwamura N.
        • Minamikawa J.
        • Nakamura Y.
        Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes.
        J Clin Endocrinol Metab. 2001; 86: 3452-3456